Regulation Of Immune Responses In Humans and in Experimental Animals
人类和实验动物免疫反应的调节
基本信息
- 批准号:8745297
- 负责人:
- 金额:$ 67.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AffectAnimalsAttentionAutophagocytosisBindingBiological AssayCell physiologyCellsChromosomes, Human, Pair 12CodeColitisCrohn&aposs diseaseDefectDendritic CellsDevelopmentEnvironmentExhibitsFeedbackFunctional RNAGastrointestinal tract structureGene AbnormalityGenesGenetic PolymorphismHematopoieticHumanImmune responseInflammatory ResponseLRRK2 geneLaboratoriesLeadLigandsMAP Kinase GeneMediatingMembraneMusMutationNF-kappa BNeurophysiology - biologic functionNuclear TranslocationParkinson DiseasePatientsPhosphorylationPolyubiquitinationProteinsPublishingRegulationReporterResearchRiskSignal TransductionStimulusTRAF6 geneTransgenic MiceTumor Necrosis Factor-alphaUlcerative ColitisWestern Blottingdectin 1gain of function mutationhuman TNF proteinimmune functioninhibition of autophagyinhibitor/antagonistinterleukin-23macrophageresponse
项目摘要
In initial studies we established with Western blot studies that the LRRK2 polymorphism was associated with increased expression of LRRK2 and was thus a gain of function mutation. This finding correlated with the effect of LRRK2 over-expression since mice with this abnormality exhibited more severe DSS-colitis. In addition, dendritic cells from LRRK2 transgenic mice exhibited increased Dectin-1-mediated induction of TNF-alpha and IL-23 associated with phosphorylation of MAPK, NF-kappaB and NFAT signaling components, positive NF-kappaB and NFAT reporter assays and nuclear translocation of NFAT.
In further studies we established that Dectin-1 stimulation of dendritic cells results in K-63 polyubiquitination of LRRK2 and that this is mediated by TAB2 and TRAF6. In addition, LRRK2 in association with TRAF6 induces K-63 polyubiquitination of NEMO and in a reporter assay both LRRK2 and TAB2 or LRRK2 and TRAF6 induces NK-kappaB in a reporter assay. Thus, LRRK2 emerges as a major facilitator of NF-kappaB activation.
In studies of the relation of LRRK2 to autophagy we showed with LRRK2KOxLC3gfp transgenic mice and LRRK2Tgxgfp transgenic mice that LRRK2 deletion and over-expression was associated with increased autophagy and decreased autophagy respectively. This result was confirmed by studies of Western blot studies of LC3 conversion. As to the mechanism of these effects on autophagy, we showed that LRRK2 binds to beclin-1 in Western blot and duolink studies, LRRK2 enhances the interaction of beclin-1 with Rubicon and LRRK2 in association with TAB2 and Rubicon induces beclin-1 degradation. Thus, LRRK2 binds to the phagosomal membrane and inhibits autophagy via it ability to enhance degradation of beclin-1. In preliminary studies we have evidence that inhibition of autophagy leads to enhanced LRRK2 expression; thus, it appears likely that increased LRRK2 expression in patients with LRRK2 polymorphisms exhibit enhanced pro-inflammatory responses to innate stimuli because such increased expression causes inhibition of autophagy and feedback LRRK2-mediated stimulation of NF-kappaB activation or NFAT activation.
In a final round of studies we established that LRRK2 inhibitors reverse the effects of LRRK2 on autophagy and NF-kappaB activation and ameliorate DSS-colitis. Thus, such inhibitors emerge as a possible treatment of patients with Crohn's disease, particularly those with LRRK2 polymorphisms.
在最初的研究中,我们通过Western印迹研究证实,LRRK2基因多态与LRRK2表达增加相关,因此是一种功能突变的获得。这一发现与LRRK2过度表达的影响有关,因为这种异常的小鼠表现出更严重的DSS-结肠炎。此外,LRRK2转基因小鼠的树突状细胞显示Dectin-1介导的TNF-α和IL-23的诱导与MAPK、NF-kappaB和NFAT信号成分的磷酸化、阳性的NF-kappaB和NFAT报告分析以及NFAT的核移位相关。
在进一步的研究中,我们证实了Dectin-1刺激树突状细胞导致K-63泛素化LRRK2,并且这是由TAB2和TRAF6介导的。此外,LRRK2与TRAF6联合诱导NEMO的K-63多泛素化,在报告实验中LRRK2与TAB2或LRRK2与TRAF6在报告实验中均诱导NK-kappaB。因此,LRRK2成为核因子-kappaB活化的主要促进器。
在LRRK2与自噬关系的研究中,我们用LRRK2KOxLC3gfp转基因小鼠和LRRK2Tgxgfp转基因小鼠表明,LRRK2的缺失和过度表达分别与自噬增加和自噬减少有关。这一结果得到了LC3转化的蛋白质印迹研究的证实。关于这些影响自噬的机制,我们在Western印迹和Duolink研究中发现LRRK2与BEKIN-1结合,LRRK2增强BEKIN-1与TAB2的相互作用,LRRK2与TAB2结合,LRRK2诱导BEKIN-1降解。因此,LRRK2结合到吞噬体膜上,并通过其促进Beclin-1的降解来抑制自噬。在初步研究中,我们有证据表明抑制自噬导致LRRK2表达增强;因此,LRRK2基因多态患者的LRRK2表达增加可能表现出对先天刺激的促炎反应增强,因为这种表达增加导致抑制自噬和反馈LRRK2介导的对核因子-kappaB或NFAT激活的刺激。
在最后一轮研究中,我们证实了LRRK2抑制剂逆转了LRRK2对自噬和核因子-kappaB激活的影响,并改善了DSS-结肠炎。因此,这种抑制剂成为克罗恩病患者的一种可能的治疗方法,特别是那些具有LRRK2基因多态的患者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Warren Strober其他文献
Warren Strober的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Warren Strober', 18)}}的其他基金
Immunoregulatory Defects In Inflammatory Bowel Disease
炎症性肠病的免疫调节缺陷
- 批准号:
9161441 - 财政年份:
- 资助金额:
$ 67.09万 - 项目类别:
CAP: Treatment of a Murine Model of Pancreatitis with a NOD1 Inhibitor
CAP:用 NOD1 抑制剂治疗小鼠胰腺炎模型
- 批准号:
8745577 - 财政年份:
- 资助金额:
$ 67.09万 - 项目类别:
CAP: Treatment of a Murine Model of Pancreatitis with a NOD1 Inhibitor
CAP:用 NOD1 抑制剂治疗小鼠胰腺炎模型
- 批准号:
8946526 - 财政年份:
- 资助金额:
$ 67.09万 - 项目类别:
Regulation Of Immune Responses In Humans and in Experimental Animals
人类和实验动物免疫反应的调节
- 批准号:
8555760 - 财政年份:
- 资助金额:
$ 67.09万 - 项目类别:
Immunoregulatory Defects In Inflammatory Bowel Disease
炎症性肠病的免疫调节缺陷
- 批准号:
8336042 - 财政年份:
- 资助金额:
$ 67.09万 - 项目类别:
Immunoregulatory Defects In Inflammatory Bowel Disease
炎症性肠病的免疫调节缺陷
- 批准号:
10014020 - 财政年份:
- 资助金额:
$ 67.09万 - 项目类别:
Immunoregulatory Defects In Inflammatory Bowel Disease
炎症性肠病的免疫调节缺陷
- 批准号:
10272022 - 财政年份:
- 资助金额:
$ 67.09万 - 项目类别:
Immunoregulatory Defects In Inflammatory Bowel Disease
炎症性肠病的免疫调节缺陷
- 批准号:
10692016 - 财政年份:
- 资助金额:
$ 67.09万 - 项目类别:
相似海外基金
The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
- 批准号:
EP/Z000920/1 - 财政年份:2025
- 资助金额:
$ 67.09万 - 项目类别:
Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
- 批准号:
FT230100276 - 财政年份:2024
- 资助金额:
$ 67.09万 - 项目类别:
ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
- 批准号:
MR/X024261/1 - 财政年份:2024
- 资助金额:
$ 67.09万 - 项目类别:
Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
- 批准号:
DE240100388 - 财政年份:2024
- 资助金额:
$ 67.09万 - 项目类别:
Discovery Early Career Researcher Award
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
- 批准号:
2232190 - 财政年份:2023
- 资助金额:
$ 67.09万 - 项目类别:
Continuing Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
- 批准号:
2337595 - 财政年份:2023
- 资助金额:
$ 67.09万 - 项目类别:
Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
- 批准号:
23K17514 - 财政年份:2023
- 资助金额:
$ 67.09万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Analysis of thermoregulatory mechanisms by the CNS using model animals of female-dominant infectious hypothermia
使用雌性传染性低体温模型动物分析中枢神经系统的体温调节机制
- 批准号:
23KK0126 - 财政年份:2023
- 资助金额:
$ 67.09万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
- 批准号:
2842926 - 财政年份:2023
- 资助金额:
$ 67.09万 - 项目类别:
Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
- 批准号:
NC/X001644/1 - 财政年份:2023
- 资助金额:
$ 67.09万 - 项目类别:
Training Grant